A review on biotechnologically derived techniques to combat COVID-19 situation

Akanksha Jain , Sonia Bajaj , Parag Jain , Ashish Majumdar , Ayushi Singh , Pranay Soni
{"title":"A review on biotechnologically derived techniques to combat COVID-19 situation","authors":"Akanksha Jain ,&nbsp;Sonia Bajaj ,&nbsp;Parag Jain ,&nbsp;Ashish Majumdar ,&nbsp;Ayushi Singh ,&nbsp;Pranay Soni","doi":"10.1016/j.hsr.2023.100112","DOIUrl":null,"url":null,"abstract":"<div><p>The severe acute respiratory illness caused by the recent global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), a new strain, is a serious health crisis. Since new virus strains are continuously developing, the 2019 coronavirus disease pandemic, also known as COVID-19, is a major concern around the world. Human mortality and economic loss have been significantly impacted by the varying degrees of severity of COVID-19 symptoms, which can range from no symptoms at all to the lethal acute respiratory distress syndrome (ARDS). Scientists around the world have taken a \"war footing\" in their search for a method to detect, treat, and immunise against the extremely dangerous COVID-19 virus so that society can return to its pre-pandemic state. Since its first publication, the number of laboratory-based and point-of-care (POC) techniques for detecting and monitoring the outbreak status of COVID-19 viral infection has increased. A rapidly growing and increasingly used approach for detecting COVID-19 is the RT-PCR-based viral nucleic acid test (NAT). Due to the urgent situation caused by the spread of COVID-19, the rapid development of effective, safe immunisations is urgently required. Rapid implementation of mass immunisation measures is the greatest challenge against the spread of the COVID-19 pandemic. The extremely contagious COVID-19 virus originated during the SARS-CoV-2 virus pandemic, and the development of diagnostics and possible vaccine candidates has been greatly aided by new biotechnologies and the interdisciplinary approaches they permit. Phase III clinical trials have shown promise for several potential vaccinations against COVID-19, and these vaccines have been granted emergency use authorisation (EUA) for distribution. However, it is critical to find most promising vaccine candidates to protect against the harmful strains that are anticipated to arise in the future and the most effective ways to give them. This review article will aid in the development of diagnostic tests and immunisations for COVID-19, which may contribute to the global eradication of virus</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health sciences review (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772632023000387","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The severe acute respiratory illness caused by the recent global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), a new strain, is a serious health crisis. Since new virus strains are continuously developing, the 2019 coronavirus disease pandemic, also known as COVID-19, is a major concern around the world. Human mortality and economic loss have been significantly impacted by the varying degrees of severity of COVID-19 symptoms, which can range from no symptoms at all to the lethal acute respiratory distress syndrome (ARDS). Scientists around the world have taken a "war footing" in their search for a method to detect, treat, and immunise against the extremely dangerous COVID-19 virus so that society can return to its pre-pandemic state. Since its first publication, the number of laboratory-based and point-of-care (POC) techniques for detecting and monitoring the outbreak status of COVID-19 viral infection has increased. A rapidly growing and increasingly used approach for detecting COVID-19 is the RT-PCR-based viral nucleic acid test (NAT). Due to the urgent situation caused by the spread of COVID-19, the rapid development of effective, safe immunisations is urgently required. Rapid implementation of mass immunisation measures is the greatest challenge against the spread of the COVID-19 pandemic. The extremely contagious COVID-19 virus originated during the SARS-CoV-2 virus pandemic, and the development of diagnostics and possible vaccine candidates has been greatly aided by new biotechnologies and the interdisciplinary approaches they permit. Phase III clinical trials have shown promise for several potential vaccinations against COVID-19, and these vaccines have been granted emergency use authorisation (EUA) for distribution. However, it is critical to find most promising vaccine candidates to protect against the harmful strains that are anticipated to arise in the future and the most effective ways to give them. This review article will aid in the development of diagnostic tests and immunisations for COVID-19, which may contribute to the global eradication of virus

抗击新冠肺炎形势的生物技术衍生技术综述
严重急性呼吸综合征冠状病毒2 (SARS-CoV2)是一种新毒株,最近在全球传播,引起严重急性呼吸系统疾病,是一场严重的健康危机。由于新的病毒株不断出现,2019年冠状病毒病大流行,也被称为COVID-19,是全世界关注的主要问题。COVID-19症状的严重程度不同,从完全没有症状到致命的急性呼吸窘迫综合征(ARDS),都对人类死亡率和经济损失产生了重大影响。世界各地的科学家已经进入“战备状态”,寻找一种检测、治疗和免疫极端危险的COVID-19病毒的方法,以便社会能够恢复到大流行前的状态。自首次发表以来,用于检测和监测COVID-19病毒感染暴发状况的实验室和护理点技术的数量有所增加。基于rt - pcr的病毒核酸检测(NAT)是一种快速发展和越来越多使用的检测COVID-19的方法。由于COVID-19蔓延造成的紧急情况,迫切需要快速开发有效、安全的免疫接种。迅速实施大规模免疫措施是应对COVID-19大流行蔓延的最大挑战。极具传染性的COVID-19病毒起源于SARS-CoV-2病毒大流行期间,新生物技术及其允许的跨学科方法极大地帮助了诊断方法和可能的候选疫苗的开发。III期临床试验显示出几种潜在的COVID-19疫苗的前景,这些疫苗已获得紧急使用授权(EUA)进行分发。然而,至关重要的是要找到最有希望的候选疫苗,以防止预计在未来出现的有害毒株,并找到最有效的接种方法。这篇综述文章将有助于开发COVID-19的诊断测试和免疫接种,这可能有助于全球根除病毒
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Health sciences review (Oxford, England)
Health sciences review (Oxford, England) Medicine and Dentistry (General)
自引率
0.00%
发文量
0
审稿时长
75 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信